Compare NRXS & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NRXS | MGLD |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.3M | 44.8M |
| IPO Year | 2023 | 2021 |
| Metric | NRXS | MGLD |
|---|---|---|
| Price | $6.26 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 113.9K | 82.8K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,685,925.00 | ★ $34,876,734.00 |
| Revenue This Year | $31.05 | N/A |
| Revenue Next Year | $146.31 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 9.18 | N/A |
| 52 Week Low | $1.33 | $0.64 |
| 52 Week High | $6.35 | $1.38 |
| Indicator | NRXS | MGLD |
|---|---|---|
| Relative Strength Index (RSI) | 64.37 | 49.07 |
| Support Level | $2.32 | $0.85 |
| Resistance Level | $6.20 | $1.37 |
| Average True Range (ATR) | 0.46 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 76.00 | 42.53 |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.